Nitric oxide regulation of microvascular oxygen

Antioxidants and Redox Signaling

Volumn 9, Issue 7, 2007, Pages 829-843

  Buerk, Donald G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; ARGININE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; HEMOGLOBIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYOGLOBIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; OXYHEMOGLOBIN; SCAVENGER; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD FLOW; CARDIOVASCULAR DISEASE; COMPUTER SIMULATION; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HYPERBARISM; HYPOXIA; MICROELECTRODE; MICROVASCULATURE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; SENSOR; STREPTOZOCIN DIABETES; TISSUE OXYGENATION; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; SIGNAL TRANSDUCTION; VASODILATION;

EID: 34250339307     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1551     Document Type: Review

References (149)

1. Alvarez S, Valdez LB, Zaobornyj T, and Boveris A. Oxygen dependence of mitochondrial nitric oxide synthase activity. Biochem Biophys Res Commun 305: 771-775, 2003.
2. Angelo M, Singel DJ, and Stamler JS. An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc Natl Acad Sci USA 103: 8366-8371, 2006.
3. Antunes F, Boveris A, and Cadenas E. On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide. Proc Natl Acad Sci USA 101: 16774-16779, 2004.
4. Arnal JF, Munzel T, Venema RC, James NL, Bai CL, Mitch WE, and Harrison DG. Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. J Clin Invest 95: 2565-2572, 1995.
5. Azarov I, Huang KT, Basu S, Gladwin MT, Hogg N, and Kim-Shapiro DB. Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J Biol Chem 280: 39024-39032, 2005.
6. Azizi F, Kielbasa JE, Adeyiga AM, Maree RD, Frazier M, Yakubu M, Shields H, King SB, and Kim-Shapiro DB. Rates of nitric oxide dissociation from hemoglobin. Free Radic Biol Med 39: 145-151, 2005.
7. Bergfeld GR and Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26: 40-47, 1992.
8. Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, and Champion HC. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 283: 923-927, 2001.
9. Boger RH. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials. Vasc Med 10(Suppl 1): S19-25, 2005.
10. Bogle RG, Baydoun AR, Pearson JD, and Mann GE. Regulation of L-arginine transport and nitric oxide release in superfused porcine aortic endothelial cells. J Physiol 490: 229-241, 1996.
11. Bohlen HG. Mechanism of increased vessel wall nitric oxide concentrations during intestinal absorption. Am J Physiol 275: 11542-550, 1998.
12. Boon EM, Huang SH, and Marletta MA. A molecular basis for NO selectivity in soluble guanylate cyclase. Nat Chem Biol 1: 53-59, 2005.
13. Briceno JC, Cabrales P, Tsai AG, and Intaglietta M. Radial displacement of red blood cells during hemodilution and the effect on arteriolar oxygen profile. Am J Physiol Heart Circ Physiol 286: 1-11223-1228, 2004.
14. Brown GC and Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356: 295-298, 1994.
15. Brunori M, Giuffre A, Nienhaus K, Nienhaus GU, Scandurra FM, and Vallone B. Neuroglobin, nitric oxide, and oxygen: functional pathways and conformational changes. Proc Natl Acad Sci USA 102: 8483-8488, 2005.
16. Bryan NS. Nitrite in nitric oxide biology: cause or consequence? A systems-based review. Free Radic Biol Med 41: 691-701, 2006.
17. Buerk DG. Can we model nitric oxide biotransport? A survey of mathematical models for a simple diatomic molecule with surprisingly complex biological activities. Annu Rev Biomed Eng 3: 109-143, 2001.
18. 2 measurements in cat carotid body. Adv Exp Med Biol 475: 337-347, 2000.
19. Buerk DG, Lamkin-Kennard K, and Jaron D. Modeling the influence of superoxide dismutase on superoxide and nitric oxide interactions, including reversible inhibition of oxygen consumption. Free Radic Biol Med 34: 1488-1503, 2003.
20. Buerk DG, Riva CE, and Cranstoun SD. Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli. Microvasc Res 52: 13-26, 1996.
21. G-hydroxy-L-arginine during high-output NO production. Am J Physiol 271: H1988-1998, 1996.
22. Butler AR, Megson IL, and Wright PG. Diffusion of nitric oxide and scavenging by blood in vasculature. Biochim Biophys Acta 1425: 168-176, 1998.
23. Cabrales P, Tsai AG, Frangos JA, and Intaglietta M. Role of endothelial nitric oxide in microvascular oxygen delivery and consumption. Free Radic Biol Med 39: 1229-1237, 2005.
24. Carlsen E and Comroe JHJ. The rate of uptake of carbon monoxide and of nitric oxide by normal human erythrocytes and experimentally produced spherocytes. J Gen Physiol 42: 83-107, 1958.
25. Cary SP, Winger JA, Derbyshire ER, and Marletta MA. Nitric oxide signaling: no longer simply on or off. Trends Biochem Sci 31:231-239, 2006.
26. Chen K and Popel AS. Theoretical analysis of biochemical pathways of nitric oxide release from vascular endothelial cells. Free Radic Biol Med 41: 668-680, 2006.
27. 2 transport in capillary-perfused tissue containing an arteriole and venule pair. Ann Biomed Eng 35: 517-529, 2007.
28. 2 transport. J Appl Physiol 100: 482-492, 2006.
29. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, and Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 345: 50-54, 1994.
30. Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang JD, Jr., Kraus D, Ho C, Gladwin MT, and Patel RP. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 107: 566-574, 2006.
31. Csordas A, Pankotai E, Snipes JA, Cselenyak A, Sarszegi Z, Cziraki A, Gaszner B, Papp L, Benko R, Kiss L, Kovacs E, Kollai M, Szabo C, Busija DW, and Lacza Z. Human heart mitochondria do not produce physiologically relevant quantities of nitric oxide. Life Sci 80: 633-637, 2007 In Press.
32. Demougeot C, Prigent-Tessier A, Marie C, and Berthelot A. Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats. J Hypertens 23: 971-978, 2005.
33. Denninger JW and Marletta MA. Guanylate cyclase and the NO/cGMP signaline pathway. Biochim Biophys Acta 1411: 334-350, 1999.
34. Dhanakoti SN, Brosnan JT, Herzberg GR, and Brosnan ME. Renal arginine synthesis: studies in vitro and in vivo. Am J Physiol 259: E437-442, 1990.
35. 2 gradients. Proc Natl Acad Sci USA 102: 5709-5714, 2005.
36. El-Farra NH, Christofides PD, and Liao JC. Analysis of nitric oxide consumption by erythrocytes in blood vessels using a distributed multicellular model. Ann Biomed Eng 31: 294-309, 2003.
37. Ellsworth ML, Forrester T, Ellis CG, and Dietrich HH. The erythrocyte as a regulator of vascular tone. Am J Physiol 269: H2155-2161, 1995.
38. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Aug J, Yuri CO, Buerk DG, Huang PL, and Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98: 2604-2609, 2001.
39. Gaston B, Singel D, Doctor A, and Stamler JS. S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med 173: 1186-1193, 2006.
40. Giulivi C, Kato K, and Cooper CE. Nitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology. Am J Physiol Cell Physiol 291: C1225-1231, 2006.
41. Gladwin MT, Raat NJ, Shiva S, Dezfulian C, Hogg N, Kim-Shapiro DB, and Patel RP. Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am J Physiol Heart Circ Physiol 291:H2026-2035, 2006.
42. Goldstein LJ, Gallagher KA, Bauer SM, Bauer RJ, Baireddy V, Liu ZJ, Buerk DG, Thom SR, and Velazquez OC. Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells 24: 2309-2318, 2006.
43. Gouverneur M, Berg B, Nieuwdorp M, Stroes E, and Vink H. Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress. J Intern Med 259: 393-400, 2006.
44. Gow AJ, Buerk DG, and Ischiropoulos H. A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J Biol Chem 272: 2841-2845, 1997.
45. Handy DE, and Loscalzo J. Nitric oxide and posttranslational modification of the vascular proteome: S-nitrosation of reactive thiols. Arterioscler Thromb Vasc Biol 26: 1207-1214, 2006.
46. Hellums JD, Nair PK, Huang NS, and Ohshima N. Simulation of intraluminal gas transport processes in the microcirculation. Ann Biomed Eng 24: 1-24, 1996.
47. Huang PL, Dawson TM, Bredt DS, Snyder SH, and Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75: 1273-1286, 1993.
48. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA. Bevan JA, and Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242, 1995.
49. Huynh NN and Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharmacol Physiol 33: 1-8, 2006.
50. Ignarro LJ, Buga GM, Wood KS, Byrns RE, and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
51. Johnson FK, Johnson RA, Peyton KJ, and Durante W. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol 288: R1057-1062, 2005.
52. Jozkowicz A, Cooke JP, Guevara I, Huk I. Funovics P, Pachinger O, Weidinger F, and Dulak J. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 51: 773-783, 2001.
53. Kashiwagi S, Izumi Y, Gohongi T, Demou ZN, Xu L, Huang PL, Buerk DG, Munn LL, Jain RK, and Fukumura D. NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels J Clin Invest 115: 1816-1837, 2005.
54. Kavdia M, Tsoukias NM, and Popel AS. Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes Am J Physiol Heart Circ Physiol 282: H2245-2253, 2002.
55. Kim-Shapiro DB, Schechter AN, and Gladwin MT. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol 26: 697-705, 2006.
56. Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K, D'Acquisto F, Makuuchi M, and Esumi H. Identification of hypoxia-inducible factor I ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem 276: 2292-2298, 2001.
57. Kline DD and Prabhakar NR. Peripheral chemosensitivity in mutant mice deficient in nitric oxide synthase. Adv Exp Med Biol 475: 571-579, 2000.
58. Kline DD, Yang T, Huang PL, and Prabhakar NR. Altered respiratory responses to hypoxia in mutant mice deficient in neuronal nitric oxide synthase. J Physiol 511: 273-287, 1998.
59. Koivisto A, Matthias A, Bronnikov G, and Nedergaard J. Kinetics of the inhibition of mitochondrial respiration by NO. FEBS Lett 417: 75-80, 1997.
60. Kosaka H and Sciyama A. Physiological role of nitric oxide as an enhancer of oxygen transfer from erythrocytes to tissues. Biochem Biophys Res Commun 218: 749-752, 1996.
61. Kuchan MJ and Frangos JA. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol 266: C628-636, 1994.
62. Kurz S and Harrison DG. Insulin and the arginine paradox. J Clin Invest 99: 369-370, 1997.
63. Kuzkaya N, Weissmann N, Harrison DG, and Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278: 22546-22554, 2003.
64. Lacza Z, Pankotai E, Csordas A, Gero D, Kiss L, Horvath EM, Kollai M, Busija DW, and Szabo C. Mitochondrial NO and reactive nitrogen species production: does mtNOS exist? Nitric Oxide 14: 162-168, 2006.
65. 2 measurements in carotid body. Adv Exp Med Biol 454: 455-460, 1998.
66. Lahiri S, Rozanov C, Roy A, Storey B, and Buerk DG. Regulation of oxygen sensing in peripheral arterial chemoreceptors. Int J Biochem Cell Biol 33: 755-774, 2001.
67. Lamkin-Kennard K, Jaron D, and Buerk DG. Modeling the regulation of oxygen consumption by nitric oxide. Adv Exp Med Biol 510: 145-159, 2003.
68. 2 in the microcirculation: a mathematical analysis. Microvasc Res 68: 38-50, 2004.
69. 2 biotransport: a computer model. Microcirculation 11: 337-349, 2004.
70. Lancaster JR, Jr. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem Res Toxicol 19: 1160-1174, 2006.
71. Lancaster JR, Jr. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 91: 8137-8141, 1994.
72. Lancaster JR, Jr. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1: 18-30, 1997.
73. Landmesser U, Harrison DG, and Drexler H. Oxidant stress-a major cause of reduced endothelial nitric oxide availability in cardiovascular disease. Eur J Clin Pharmacol 62: 13-19, 2006.
74. Lass A, Suessenbacher A, Wolkart G, Mayer B, and Brunner F. Functional and analytical evidence for scavenging of oxygen radicals by L-arginine. Mol Pharmacol 61: 1081-1088, 2002.
75. Lee Y, Yang J, Rudich SM, Schreiner RJ, and Meyerhoff ME. Improved planar amperometric nitric oxide sensor based on platinized platinum anode. 2. Direct real-time measurement of NO generated from porcine kidney slices in the presence of l-arginine, l-arginine polymers, and protamine. Anal Chem 76: 545-551, 2004.
76. Liao JC, Hein TW, Vaughn MW, Huang KT, and Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci USA 96: 8757-8761, 1999.
77. Lipton AJ, Johnson MA, Macdonald T, Lieberman MW, Gozal D, and Gaston B. S-nitrosothiols signal the ventilatory response to hypoxia. Nature 413: 171-174, 2001.
78. Lu X and Kassab GS. Nitric oxide is significantly reduced in ex vivo porcine arteries during reverse flow because of increased superoxide production. J Physiol 561: 575-582, 2004.
79. Malinski T, Taha Z, Grunfeld S, Patton S, Kapturczak M, and Tomboulian P. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem Biophys Res Commun 193: 1076-1082, 1993.
80. Mason MG, Nicholls P, Wilson MT, and Cooper CE. Nitric oxide inhibition of respiration involves both competitive (heme) and noncompetitive (copper) binding to cytochrome c oxidase. Proc Natl Acad Sci USA 103: 708-713, 2006.
81. McDonald KK, Zharikov S, Block ER, and Kilbcrg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox." J Biol Chem 272: 31213-31216, 1997.
82. Meurs H, Maarsingh H, and Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci 24: 450-455, 2003.
83. Milstien S and Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263: 681-684, 1999.
84. Ming XF, Barandier C, Viswambharan H, Kwak BR, Mach F, Mazzolai L, Hayoz D, Ruffieux J, Rusconi S, Montani JP, and Yang Z. Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation 110: 3708-3714, 2004.
85. Mittermayer F, Krzyzanowska K, Exner M, Mlekusch W, Amighi J, Sabeti S, Minar E, Muller M, Wolzt M, and Schillinger M. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arterioscler Thromb Vasc Biol 26: 2536-2540, 2006.
86. Moens AL and Kass DA. Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 26: 2439-2444, 2006.
87. Moncada S and Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147 (Suppl I): S193-201, 2006.
88. Moncada S, Palmer RMJ, and Higgs EA. Nitric-oxide-Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
89. Morris SMJ. Enzymes of arginine metabolism J Nutr 134: 2743S-2747S, 2004.
90. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, and Isner JM. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97: 99-107, 1998.
91. Nagababu E, Ramasamy S, and Rilkind JM. S-nitrosohemoglobin: a mechanism for its formation in conjunction with nitrite reduction by deoxyhemoglobin. Nitric Oxide 15: 20-29, 2006.
92. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, and Ignarro LJ. Nitric oxide and atherosclerosis: An update. Nitric Oxide 15: 265-279, 2006.
93. 2 increases intire oxide release from endothelial cells. Am J Physiol Heart Circ Physiol 285: H507-11515, 2003.
94. Olearczyk JJ, Ellsworth ML, Stephenson AH, Lonigro AJ, and Sprague RS. Nitric oxide inhibits ATP release from erythrocytes. J Pharmacol Exp Ther 309: 1079-1084, 2004.
95. 1. Am J Physiol Heart Circ Physiol 287: H748-754, 2004.
96. Pacher P and Szabo C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr Opin Pharmacol 6: 136-141, 2006.
97. Palacios-Callender M, Hollis V, Frakich N, Mateo J, and Moncada S. Cytochrome c oxidase maintains mitochondrial respiration during partial inhibition by nitric oxide. J Cell Sci 120: 160-165, 2007.
98. Palm F, Buerk DG, Carlsson PO, Hansell P, and Liss P. Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation. Diabetes 54: 3282-3287, 2005.
99. Palmer LA, Gaston B, and Johns RA. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol Pharmacol 58: 1197-1203, 2000.
100. Palmer RM, Ashton DS, and Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988.
101. Palmer RM, Ferrige AG, and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
102. Pardridge WM and Jefferson LS. Liver uptake of amino acids and carbohydrates during a single circulatory passage. Am J Physiol 228: 1155-1161, 1975.
103. Petersen LC. The effect of inhibitors on the oxygen kinetics of cytochrome c oxidase. Biochim Biophys Acta 460: 299-307, 1977.
104. Pryor WA, Houk KN, Foote CS, Fukuto JM, Ignarro LJ, Squadrito GL, and Davies KJ. Free radical biology and medicine: it's a gas, man! Am J Physiol Regul Integr Comp Physiol 291: R491-511, 2006.
105. Rayner BS, Wu BJ, Raftery M, Stocker R, and Witting PK. Human S-nitroso oxymyoglobin is a store of vasoactive nitric oxide. J Biol Chem 280: 9985-9993, 2005.
106. Rodriguez-Crespo I, Gerber NC, and Ortiz de Montellano PR. Endothelial nitric-oxide synthase. Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation. J Biol Chem 271:11462-11467, 1996.
107. Ruiz-Stewart I, Tiyyagura SR, Lin JE, Kazerounian S, Pitari GM, Schulz S, Martin E, Murad F, and Waldman SA. Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism. Proc Natl Acad Sci USA 101: 37-42, 2004.
108. Sandau KB, Fandrey J, and Brune B. Accumulation of HIF-I alpha under the influence of nitric oxide. Blood 97: 1009-1015, 2001.
109. Shaul PW. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J Physiol 547: 21-33, 2003.
110. Shibata M, Ichioka S, and Kamiya A. Estimating oxygen consumption rates of arteriolar walls under physiological conditions in rat skeletal muscle. Am J Physiol Heart Circ Physiol 289: H295-300, 2005.
111. Shibata M, Ichioka S, and Kamiya A. Nitric oxide modulates oxygen consumption by arteriolar walls in rat skeletal muscle. Am J Physiol Heart Circ Physiol 289: H2673-2679, 2005.
112. Shibata M, Qin K, Ichioka S, and Kamiya A. Vascular wall energetics in arterioles during nitric oxide-dependent and -independent vasodilation. J Appl Physiol 100: 1793-1798, 2006.
113. Singel DJ and Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol 67: 99-145, 2005.
114. Son H, Hawkins RD, Martin K, Kiebler M, Huang PL, Fishman MC, and Kandel ER. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 87: 1015-1023, 1996.
115. Sprague RS, Ellsworth ML, Stephenson AH, and Lonigro AJ. Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol 281: C1158-1164, 2001.
116. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, and Piantadosi CA. Blood flow regulation by S- nitrosohemoglobin in the physiological oxygen gradient. Science 276: 2034-2037, 1997.
117. Steppan J, Ryoo S, Schuleri KH, Gregg C, Hasan RK, White AR, Bugaj LJ, Khan M, Santhanam L, Nyhan D, Shoukas AA, Hare JM, and Berkowitz DE. Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc Natl Acad Sci USA 103: 4759-4764, 2006.
118. Stepuro TL and Zinchuk VV. Nitric oxide effect on the hemoglobin-oxygen affinity. J Physiol Pharmacol 57: 29-38, 2006.
119. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1411: 217-230, 1999.
120. Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL, and Wiseman J. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 266: 6259-6263, 1991.
121. Suzuki T, Suematsu M, and Makino R. Organic phosphates as a new class of soluble guanylate cyclase inhibitors. FEBS Lett 507: 49-53, 2001.
122. Taylor PD and Poston L. The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br J Pharmacol 113: 801-808, 1994.
123. Thom SR, Bhopale V, Fisher D, Mancvich Y, Huang PL, and Buerk DG. Stimulation of nitric oxide synthase in cerebral cortex due to elevated partial pressures of oxygen: an oxidative stress response. J Neurobiol 51: 85-100, 2002.
124. Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH, and Buerk DG. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol 290: H1378-1386, 2006.
125. Thom SR and Buerk DG. Nitric oxide synthesis in brain is stimulated by oxygen. Adv Exp Med Biol 510: 133-137, 2003.
126. Thomn SR, Fisher D, Zhang J, Bhopale VM, Cameron B, and Buerk DG. Neuronal nitric oxide synthase and N-methyl-D-aspartate neurons in experimental carbon monoxide poisoning. Toxicol Appl Pharmacol 194: 280-295, 2004.
127. Thom SR, Fisher D, Zhang J, Bhopale VM, Ohnishi ST, Kotake Y, Ohnishi T, and Buerk DG. Stimulation of perivascular nitric oxide synthesis by oxygen. Am J Physiol Heart Circ Physiol 284: H1230-1239, 2003.
128. 2. Proc Natl Acad Sci USA 98: 355-360, 2001.
129. Tsai AG, Acero C, Nance PR, Cabrales P, Frangos JA, Buerk DG, and Intaglietta M. Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circ Physiol 288: H1730-1739, 2005.
130. Tsikas D, Roger RH, Sandmann J, Bode-Boger SM, and Frolich JC. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett 478: 1-3, 2000.
131. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, and Isner JM. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 3: 879-886, 1997.
132. Tsutsui M, Shimokawa H, Morishita T, Nakashima Y, and Yanagihara N. Development of genetically engineered mice lacking all three nitric oxide synthases. J Pharmacol Sci 102: 147-154, 2006.
133. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84, 2007.
134. Vaughn MW, Huang KT, Kuo L, and Liao JC. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem 275: 2342-2348, 2000.
135. Vaughn MW, Kuo L, and Liao JC. Effective diffusion distance of nitric oxide in the microcirculation. Am J Physiol 274: H1705-H1714, 1998.
136. Vaughn MW, Kuo L, and Liao JC. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am J Physiol 274: H2163-2176, 1998.
137. Vukosavljevic N, Jaron D, Barbee KA, and Buerk DG. Quantifying the L-argininc paradox in vivo. Microvasc Res 71: 48-54, 2006.
138. Watford M. The urea cycle: a two-compartment system. Essays Biochem 26: 49-58, 1991.
139. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, and Liew FY. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-411, 1995.
140. Yang J, Clark JW, Bryan RM, and Robertson CS. Mathematical modeling of the nitric oxide/cGMP pathway in the vascular smooth muscle cell. Am J Physiol Heart Circ Physiol 289: H886-897, 2005.
141. Yu J, deMuinck ED, Zhuang Z, Drinane M, Kauser K, Rubanyi GM, Qian HS, Murata T, Escalante B, and Sessa WC. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci USA 102: 10999-11004, 2005.
142. Zani BG, and Bohlen HG. Transport of extracellular L-arginine via cationic amino acid transporter is required during in vivo endothelial nitric oxide production. Am J Physiol Heart Circ Physiol 289: H1381-1390, 2005.
143. Zheng JS, Yang XQ, Lookingland KJ, Fink CD, Hesslinger C, Kapatos G, Kovesdi I, and Chen AF. Gene transfer of human guanosine 5′-triphosphate cyclohydrolase 1 restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108: 1238-1245, 2003.
144. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, and Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997.
145. Zimmermann N and Rothenberg ME. The arginine-arginase balance in asthma and lung inflammation. Eur J Pharmacol 533: 253-262, 2006.
146. Zinchuk V and Borisiuk M. The effect of NO synthase inhibition on blood oxygen-carrying function during hyperthermia in rats. Respir Physiol 113: 39-45, 1998.
147. Zinchuk VV and Dorokhina LV. Blood oxygen transport in rats under hypothermia combined with modification of the L-arginine-NO pathway. Nitric Oxide 6: 29-34, 2002.
148. Zoccali C. Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move. J Hypertens 24: 611-619, 2006.
149. Zweier JL, Samouilov A, and Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta 1411:250-262, 1999.